Intersect ENT, Inc. (XENT) News
Filter XENT News Items
XENT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XENT News Highlights
- XENT's 30 day story count now stands at 3.
- Over the past 24 days, the trend for XENT's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about XENT are BHP, TFX and TMDX.
Latest XENT News From Around the Web
Below are the latest news stories about Intersect ENT Inc that investors may wish to consider to help them evaluate XENT as an investment opportunity.
Teleflex (TFX) Q4 Earnings and Revenues Surpass EstimatesTeleflex (TFX) delivered earnings and revenue surprises of 1.98% and 1.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
TransMedics (TMDX) Reports Q4 Loss, Tops Revenue EstimatesTransMedics (TMDX) delivered earnings and revenue surprises of -6.98% and 26.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Havens Advisors Llc Buys BHP Group PLC, CyrusOne Inc, NeoPhotonics Corp, Sells , ,New York, NY, based Investment company Havens Advisors Llc (Current Portfolio) buys BHP Group PLC, CyrusOne Inc, NeoPhotonics Corp, Rogers Corp, Triple-S Management Corp, sells , , , Cloudera Inc, during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Havens Advisors Llc. |
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource UtilizationMENLO PARK, Calif., January 25, 2022--Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization |
Intersect ENT, Inc. (NASDAQ:XENT) Expected to Announce Quarterly Sales of $37.13 MillionAnalysts expect that Intersect ENT, Inc. (NASDAQ:XENT) will post sales of $37.13 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Intersect ENTs earnings, with estimates ranging from $36.53 million to $37.82 million. Intersect ENT reported sales of $28.23 million in the same quarter last year, which would [] |
Parametric Portfolio Associates LLC Sells 3,012 Shares of Intersect ENT, Inc. (NASDAQ:XENT)Parametric Portfolio Associates LLC lowered its stake in shares of Intersect ENT, Inc. (NASDAQ:XENT) by 8.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 32,861 shares of the medical equipment providers stock after selling 3,012 shares during the quarter. Parametric Portfolio Associates LLCs holdings [] |
Intersect ENT, Inc. (NASDAQ:XENT) Expected to Announce Earnings of -$0.35 Per ShareEquities analysts expect Intersect ENT, Inc. (NASDAQ:XENT) to report earnings per share (EPS) of ($0.35) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Intersect ENTs earnings, with the lowest EPS estimate coming in at ($0.42) and the highest estimate coming in at ($0.30). Intersect ENT reported earnings per share of [] |
3,904 Shares in Intersect ENT, Inc. (NASDAQ:XENT) Bought by Lumature Wealth Partners LLCLumature Wealth Partners LLC bought a new stake in shares of Intersect ENT, Inc. (NASDAQ:XENT) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,904 shares of the medical equipment providers stock, valued at approximately $106,000. Several other institutional investors have also bought [] |
Why Is Intersect ENT (XENT) Down 0.6% Since Last Earnings Report?Intersect ENT (XENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Zacks: Analysts Expect Intersect ENT, Inc. (NASDAQ:XENT) Will Announce Earnings of -$0.35 Per ShareBrokerages predict that Intersect ENT, Inc. (NASDAQ:XENT) will post ($0.35) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Intersect ENTs earnings. The lowest EPS estimate is ($0.42) and the highest is ($0.30). Intersect ENT posted earnings of ($0.54) per share during the same quarter [] |